Hugel Inc
KOSDAQ:145020
Hugel Inc
Operating Expenses
Hugel Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
H
|
Hugel Inc
KOSDAQ:145020
|
Operating Expenses
-₩128.4B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
Celltrion Inc
KRX:068270
|
Operating Expenses
-₩400.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-21%
|
|
SK Bioscience Co Ltd
KRX:302440
|
Operating Expenses
-₩154.2B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
Green Cross Corp
KRX:006280
|
Operating Expenses
-₩450.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-9%
|
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Operating Expenses
-₩98B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
A
|
Alteogen Inc
KOSDAQ:196170
|
Operating Expenses
-₩40.9B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
See Also
What is Hugel Inc's Operating Expenses?
Operating Expenses
-128.4B
KRW
Based on the financial report for Dec 31, 2023, Hugel Inc's Operating Expenses amounts to -128.4B KRW.
What is Hugel Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-13%
Over the last year, the Operating Expenses growth was -9%. The average annual Operating Expenses growth rates for Hugel Inc have been -22% over the past three years , -13% over the past five years .